Chimeric Therapeutics is the ASX leader in cell therapy. As the only clinical stage, cell therapy biotechnology company in Australia, our focus is on discovering, developing and commercialising novel cell therapies with the most potential for patients. ASX: CHM
Headquarters:
Australia
Company Type:
MNC / Large Enterprise
Company size:
1-10 Employees
Year Founded:
2020 (5 years)
Address:
62 LYGON ST; LEVEL 3; CARLTON, VICTORIA 3053, AU
LOW
spending power
